Skip to main content
SpringerLink
Log in

Schwerpunkt Zervixkarzinom

Radiochemotherapie des Zervixkarzinoms*

  • Schwerpunkt
  • Published:
InFo Hämatologie + Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2

Literatur

  1. https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2023/kid_2023_c53_gebaermutterhals.pdf abgerufen am 8. Februar 2024

  2. Bhatla N et al. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(2):22-36

  3. Knoth J et al. Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging—An analysis from the EMBRACE study. Gynecol Oncol. 2020;159(1):136-41

  4. Lucia F et al. Multicentric development and evaluation of (18)F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer. Eur J Nucl Med Mol Imaging. 2023;50(8):2514-28

  5. Su CH et al. Survival effect of pre-RT PET-CT on cervical cancer: Image-guided intensity-modulated radiation therapy era. Front Oncol. 2023;13:1012491

  6. Weyl A et al. PET-MRI for evaluation of response to radiochemotherapy in patients with locally advanced cervical cancer. Int J Gynecol Cancer. 2023;33(5):676-82

  7. Cibula D et al. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023. Radiother Oncol. 2023:184:109682

  8. Rose PG et al. Nomograms predicting progression-free survival, overall survival, and pelvic recurrence in locally advanced cervical cancer developed from an analysis of identifiable prognostic factors in patients from NRG oncology/gynecologic oncology group randomized trials of Chemoradiotherapy. J Clin Oncol. 2015;33(19):2136-42

  9. Xue R et al. The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: a meta-analysis. Gynecol Oncol. 2018;150(3):412-19

  10. Lorvidhaya V et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial. Int J Radiat Oncol Biol Phys. 2003;55(5):1226-32

  11. Tanderup K et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol. 2016;120(3):441-46

  12. Pötter R et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021;22(4):538-47

  13. Sturdza A et al. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol. 2016;120(3):428-33

  14. Petric P et al. Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study. Radiother Oncol. 2021;157:24-31

  15. Schmid MP et al. Risk factors for local failure following Chemoradiation and magnetic resonance image-guided Brachytherapy in locally advanced cervical cancer: results from the EMBRACE-I study. J Clin Oncol. 2023;41(10):1933-42

  16. Sturdza AE et al. Nomogram predicting overall survival in patients with locally advanced cervical cancer treated with Radiochemotherapy including image-guided Brachytherapy: a retro-EMBRACE study. Int J Radiat Oncol Biol Phys. 2021;111(1):168-77

  17. Fokdal L et al. Image guided adaptive brachytherapy with combined intracavitary and interstitial technique improves the therapeutic ratio in locally advanced cervical cancer: analysis from the retroEMBRACE study. Radiother Oncol. 2016;120(3):434-40

  18. Jensen NB et al. Dose-volume effects and risk factors for late diarrhea in cervix cancer patients after Radiochemotherapy with image guided adaptive Brachytherapy in the EMBRACE I study. Int J Radiat Oncol Biol Phys. 2021;109(3):688-700

  19. Spampinato S et al. Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis. Radiother Oncol. 2021;158:312-20

  20. Spampinato S et al. Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis. Radiother Oncol. 2021;158:300-8

  21. Vittrup AS et al. Persistence of late substantial patient-reported symptoms (LAPERS) after Radiochemotherapy including image guided adaptive Brachytherapy for locally advanced cervical cancer: a report from the EMBRACE study. Int J Radiat Oncol Biol Phys. 2021;109(1):161-73

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Radioonkologie, Medizinische Universität Wien, Währinger Gürtel 18–20, 1090, Wien, Österreich

    Alina Sturdza &  Johannes Knoth

Authors
  1. Alina Sturdza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johannes Knoth
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sturdza, A., Knoth, J. Radiochemotherapie des Zervixkarzinoms*. InFo Hämatol Onkol 27, 10–13 (2024). https://doi.org/10.1007/s15004-024-0496-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-024-0496-2

Search

Navigation